Systematic Review of Monitoring Criteria to interpret CA 125 Increments during First-Line Chemotherapy and the Subsequent Follow-Up Period among Patients with Advanced Epithelial Ovarian Cancer

Suher Othman Abu Hassan, Dorte Lisbet Nielsen, Malgorzata Tuxen, Robert C. Bast, Georg Söletormos

Cite this